Mikael Dolsten, head of research at Pfizer, appointed visiting professor at Lund University
Published 11 December 2020 Mikael Dolsten (Photo: Pfizer) Mikael Dolsten, head of research at Pfizer, who led the development of Pfizer’s and BioNTech’s Covid-19 vaccine, will take up the appointment of visiting professor of Pharmacology at Lund University in Sweden on 1 January 2021. “During my years as a student and researcher in Lund I had many mentors who inspired me. I want to give something